Brown, M.A. (2004). Prescriptive authority and barriers to NP practice. The Nurse Practitioner, 29(3), 28–35.27 Kaplan, L., & Brown, M.A. (2006). What is “true” professional autonomy? Nurse Practitioner, 31(3), 37.
28 Kraus, E., & DuBois, J.M. (2017). Knowing your limits: A qualitative study of physician and nurse practitioner perspectives of NP independence in primary care. Journal of General Internal Medicine, 32(3), 284–290.
29 Landsperger, J.S., Semler, M.W., Wang, L., et al. (2016). Outcomes of nurse practitioner‐delivered critical care: A prospective cohort study. Chest, 149(5), 1146–1154.
30 Laurant, M., van der Biezen, M., Wijers, N., et al. (2018). Nurses as substitutes for doctors in primary care. Cochrane Database Systematic Reviews, 7(7), CD001271.
31 Lenz, E.R., Mundinger, M.O., Kane, R.L., et al. (2004). Primary care outcomes in patients treated by nurse practitioners or physicians: two year follow up. Medical Care Research and Review, 51(3), 332–351.
32 Lowry, J.A., & Leeder, J.S. (2015). Over‐the‐counter medications: Update on cough and cold preparations. Pediatrics in Review, 36(7), 286–298.
33 McVeigh, D.M. (2001). Polypharmacy in the older population: Recommendations for improved clinical practice. Topics in Emergency Medicine, 23(3), 68–75.
34 National Council of State Boards of Nursing. (2020). Member board profiles. Retrieved from https://www.ncsbn.org/profiles.htm. (Accessed 7 September 2020.)
35 National Conference of State Legislatures. (2020). State medical marijuana laws. Retrieved from http://www.ncsl.org/research/health/state‐medical‐marijuana‐laws.aspx. (Accessed 7 September 2020.)
36 Newhouse, R.P., Stanik‐Hutt, J., White, K.M., et al. (2011). Advance practice nurse outcomes 1990–2008: A systematic review. Nursing Economics, 29(5), 1–22.
37 Ohman‐Strickland, P.A., Orzano, A.J., Hudson, S.V., et al. (2008). Quality of diabetes care in family medicine practices: Influence of nurse practitioners and physician’s assistants. Annals of Family Medicine, 6(1), 14–22.
38 O’Keefe, M.E. (2001). Nursing practice and the law. Philadelphia: F.A. Davis Company.
39 Phillips, S.J. (2007). A comprehensive look at the legislative issues affecting advanced nursing practice. The Nurse Practitioner, 32(1), 14–17.
40 Prescott, P.A., & Driscoll, L. (1980). Evaluating nurse practitioner performance. Nurse Practitioner, 1(1), 28–32.
41 Safriet, B.J. (1992). Health care dollars and regulatory sense: The role of advanced practice nursing. Yale Journal on Regulation, 9(2), 417–488.
42 Safriet, B.J. (2002). Closing the gap between can and may in healthcare provider’s scopes of practice: A primer for policymakers. Yale Journal on Regulation, 19(2), 301–334.
43 Schommer, J.C., Worley, M.M., Kjos, A.L., et al. (2009). A thematic analysis for how patients, prescribers, experts, and patient advocates view the prescription choice process. Research in Social and Administrative Pharmacy, 5(2), 154–169.
44 Schumacher, K.L., & Meleis, A.I. (1994). Transitions: A central concept in nursing. Image: The Journal of Nursing Scholarship, 26(2), 119–127.
45 Simonson, D.C., Ahern, M.M., & Hendryx, M.S. (2007). Anesthesia staffing and anesthetic complications during cesarean delivery: A retrospective analysis. Nursing Research, 56(1), 9–17.
46 Spitzer, W.O., Sackett, D.L., Sibley, J.C., et al. (1974). The Burlington randomized trial of the nurse practitioner. New England Journal of Medicine, 290(3), 252–256.
47 Title 21 – Food and Drugs. (1993). 21 USC Chapter 13, subchapter I, Part B, 1993: Authority to control; standards and schedules. Retrieved from https://uscode.house.gov/view.xhtml?path=/prelim@title21/chapter13/subchapter1/partB&edition=prelim. (Accessed 7 September 2020.)
48 Torrey, T. (2019). Where to find free or low‐cost prescription drugs. Very Well Health. Retrieved from https://www.verywellhealth.com/free‐low‐cost‐prescription‐drugs‐stores‐2615299. (Accessed 7 September 2020.)
49 Ulrich, C.M., & Soeken, K. (2005). A path analytic model of ethical conflict in practice and autonomy in a sample of nurse practitioners. Nursing Ethics, 12(3), 319–325.
50 Washington State Health Care Authority. (2020). Patient review and coordination program. Retrieved from https://www.hca.wa.gov/billers‐providers‐partners/programs‐and‐services/patient‐review‐and‐coordination‐prc. (Accessed 7 September 2020.)
51 Weiland, S.A. (2008). Reflections on independence in nurse practitioner practice. Journal of the American Academy of Nurse Practitioners, 20(7), 345–352.
52 Weiland, S.A. (2015). Understanding nurse practitioner autonomy. Journal of the American Association of Nurse Practitioners, 27(2), 95–104.
53 Wood, S.F., Podrasky, J., McMonagle, M.A., et al. (2017). Influence of pharmaceutical marketing on Medicare prescriptions in the District of Columbia. PLoS One, 12(10), e0186060.
54 World Health Organization. (2002). Promoting rational use of medicines: Core components. WHO Policy Perspectives on Medicines. Retrieved from http://archives.who.int/tbs/rational/h3011e.pdf. (Accessed 7 September 2020.)
55 Wright, W.L., Romboli, J.E., DiTulio, M.A., et al. (2011). Hypertension treatment and control within an independent nurse practitioner setting. American Journal of Managed Care, 17(1), 58–65.
Конец ознакомительного фрагмента.
Текст предоставлен ООО «ЛитРес».
Прочитайте эту книгу целиком, купив полную легальную версию на ЛитРес.
Безопасно оплатить книгу можно банковской картой Visa, MasterCard, Maestro, со счета мобильного телефона, с платежного терминала, в салоне МТС или Связной, через PayPal, WebMoney, Яндекс.Деньги, QIWI Кошелек, бонусными картами или другим удобным Вам способом.
